Home › Funds › TCG Crossover Management, LLC › ADCT
TCG Crossover Management, LLC position in ADCT
ADC THERAPEUTICS SA · Health Care
TCG Crossover Management, LLC reported holding 11,390,175 shares of ADCT (ADC THERAPEUTICS SA) in its Q2 2026 13F filing — a position valued at US$12.2M, representing 0.29% of its reported portfolio and ranking #44 among its reported holdings. TCG Crossover Management, LLC has disclosed ADCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's ADCT position evolved
TCG Crossover Management, LLC first disclosed a stake in ADCT in Q3 2025 at 1,390,175 shares (US$5.6M). The position peaked in Q1 2026 at 11,390,175 shares, worth US$42.7M. Across 4 filings, TCG Crossover Management, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 11,390,175 shares valued at US$12.2M. Notable position changes include a 719% increase in Q4 2025 (shares rose 6% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 1.39M | $5.56M | New |
| Q4 2025 | 11.39M | $40.21M | Add |
| Q1 2026 | 11.39M | $42.71M | Hold |
| Q2 2026 | 11.39M | $12.19M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ADCT and 13F data
ADCT (ADC THERAPEUTICS SA) is a Health Care company. 27 other funds we track also report a position in ADCT — the largest reported positions include Redmile Group, LLC (US$12.3M), Prosight Management, LP (US$8.4M), Blue Owl Capital Holdings LP (US$785K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ADCT
- Redmile Group, LLC 11.53M sh · $12.33M · Q2 2026
- Prosight Management, LP 7.82M sh · $8.37M · Q2 2026
- Blue Owl Capital Holdings LP 733.57K sh · $784.92K · Q2 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held ADCT?
TCG Crossover Management, LLC has disclosed ADCT holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is TCG Crossover Management, LLC's current position in ADCT?
As of Q2 2026, TCG Crossover Management, LLC holds 11.39M shares of ADCT (ADC THERAPEUTICS SA), valued at $12.19M, representing 0.29% of its reported portfolio and ranking #44.
Has TCG Crossover Management, LLC been buying or selling ADCT?
In the latest 13F filing (Q2 2026), TCG Crossover Management, LLC held unchanged its position in ADCT. The position peaked in Q1 2026 at 11.39M shares.
Which other funds hold ADCT?
Other major institutional holders of ADCT include Redmile Group, LLC, Prosight Management, LP, Blue Owl Capital Holdings LP, among 27 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.